Mutual Funds
Nippon India Pharma Fund(G)
Equity  |   Very High  |   Equity - Sectoral Fund - Pharma & Health Care
573.15   -1.29
NAV(₹) as on 14/8/2026 		-0.22%
  1D 		10.32%
  1Y 		18.10%
  3Y 		13.38%
  5Y
Nippon India Pharma Fund(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio:
1.85 		Launch Date:
05 Jun 2004
Exit Load:
1% on or before 1M, Nil after 1M 		AUM:
₹ 9,279.11 Crs
Lock-in:
Nil 		Investing Style:
Large Growth
Portfolio Price To Book Value:
7.85 		Min. Investment:
SIP : ₹ 100.00
Lumpsum : ₹ 5,000.00
Scheme Benchmark:
NA
Fund Manager:
Sailesh Raj Bhan

FUND OBJECTIVE

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

LATEST ASSET & PORTFOLIO ALLOCATION Others Equity
as on 31/7/2026 2.68 % 97.32 %
TOP HOLDINGS

Sun Pharmaceutical Industries Ltd.
13.31 %

Lupin Ltd.
7.25 %

Divi's Laboratories Ltd.
6.52 %

Cipla Ltd.
6.03 %

Apollo Hospitals Enterprise Ltd.
5.30 %

Dr. Reddy's Laboratories Ltd.
5.01 %

Mankind Pharma Ltd.
3.74 %

Sai Life Sciences Ltd.
3.62 %

Ajanta Pharma Ltd.
3.41 %

Max Healthcare Institute Ltd.
3.15 %

See All Holding
ALLOCATION BY MARKET CAP (Equity)
ALLOCATION BY RATING (Debt & Others)

No Data

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs
73.51 %

Hospital & Healthcare Servic
19.66 %

Retailing
2.69 %

Business Support
1.46 %

See All Sectors
PORTFOLIO CHARACTERISTICS (Debt)

No Data

5 YEAR HISTORY

Financial Year 2021-22 2022-23 2023-24 2024-25 2025-26
NAV (31/3/2026) 290.14 270.59 428.87 481.27 489.71
Net Assets (Rs Crores) 4,93,188.52 4,30,446.45 7,12,528.46 8,08,096.99 7,89,824.17
Scheme Returns(%)(Absolute) 14.83 -6.85 58.24 10.94 3.30
B'mark Returns(%)(Absolute) NA NA NA NA NA
Category Rank 43/75 65/76 17/90 30/102 25/120
RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details Inception Date Aum(₹ Crs) 1Y 3Y 5Y Since Inception
MDB Logo
HDFC Pharma and Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  21.42   +-0.01  
4/10/2023 ₹ 2,939.98 23.63% - - 30.64%
MDB Logo
WOC Pharma and Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  16.78   +-0.05  
6/2/2024 ₹ 824.9 19.70% - - 22.80%
MDB Logo
PGIM India Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  12.14   +-0.03  
6/12/2024 ₹ 111.64 21.89% - - 12.18%
MDB Logo
Bajaj Finserv Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  11.65   +-0.09  
27/12/2024 ₹ 376.77 19.42% - - 9.83%
MDB Logo
Baroda BNP Paribas Health and Wellness Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  10.69   +-0.05  
27/6/2025 ₹ 519.48 8.54% - - 6.08%
MDB Logo
Bandhan Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  11.24   +-0.01  
28/11/2025 ₹ 319.48 - - - 12.37%
MDB Logo
Kotak Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  16.66   +0.03  
11/12/2023 ₹ 682.39 22.53% - - 21.02%
MDB Logo
ITI Pharma & Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  18.03   +-0.06  
8/11/2021 ₹ 262.84 10.34% 18.08% - 13.16%
MDB Logo
Nippon India Pharma Fund(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  573.15   +-1.29  
5/6/2004 ₹ 9,279.11 10.32% 18.10% 13.38% 20.00%
MDB Logo
Tata India Pharma & Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  33.63   +-0.05  
28/12/2015 ₹ 1,541.42 8.37% 18.59% 13.82% 12.08%